Efficacy and safety of multiple doses of levomilnacipran extended-release for the treatment of major depressive disorder
Qunlian Huang,1 Xiaoyan Zhong,1 Ye Yun,1 Bin Yu,2 Yilan Huang1 1Department of Pharmacy, The Affiliated Hospital of Southwest Medical University, 2Department of Clinical Pharmacy, School of Pharmacy, Southwest Medical University, Luzhou, Sichuan Province, People’s Republic of China Object...
Saved in:
Main Authors: | Huang Q, Zhong X, Yun Y, Yu B, Huang Y |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/db5d6893455c4d9fb46afab643defdfb |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Clinical and Neurocognitive Predictors of Functional Outcome in Depressed Patients with Partial Response to Treatment: One Year Follow-Up Study
by: Castellano S, et al.
Published: (2020) -
The efficacy and safety of 10 mg vortioxetine in the treatment of major depressive disorder: a meta-analysis of randomized controlled trials
by: Li G, et al.
Published: (2016) -
Pioglitazone could induce remission in major depression: a meta-analysis
by: Colle R, et al.
Published: (2016) -
Elevated peripheral blood glutamate levels in major depressive disorder
by: Inoshita M, et al.
Published: (2018) -
The role of new antidepressants in clinical practice in Canada: a brief review of vortioxetine, levomilnacipran ER, and vilazodone
by: McIntyre RS
Published: (2017)